News
Mark Kirton, who experienced his most productive seasons of his NHL career with the Detroit Red Wings in the early 1980s, ...
Yet another biotech is facing a delay from the Food and Drug Administration as the agency reels from intense staffing cuts. | Yet another biotech is facing a delay from the Food and Drug ...
Researchers genetically reprogrammed mouse nerve cells to reverse cell aging, delaying the onset of ALS symptoms in the animals.
1d
Health on MSNWhat Is the Difference Between ALS and MS?
Medically reviewed by Nicholas R. Metrus, MD Multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS, also called Lou Gehrig's disease) are both diseases that affect your central nervous system ...
I have ALS, also known as amyotrophic lateral sclerosis or Lou Gehrig’s disease. Named for the famous baseball player, it’s a neuro-degenerative disorder. But I’m not here to discuss the ...
SNUG01 showed favorable safety and signs of early clinical efficacy in a recently completed investigator-initiated trial in China, the firm said.
In that moment, things clicked. A year ago, my father died after an absolutely brutal battle with amyotrophic lateral ...
By decoding neural signals linked to a person’s inner monologue, researchers enabled communication for individuals with ...
A brain-computer interface has enabled people with paralysis to turn their thoughts directly into words, requiring less ...
In a recent study, scientists successfully decoded not only the words people tried to say but the words they merely imagined saying.
The Company plans to hold an end-of-Phase 2 Type B meeting with the FDA in the third quarter of 2025. This meeting will review results from the Phase 2 VISIONARY-MS trial and discuss the planned Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results